RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 2:42 AM
Followers: 439
Posts Today: 1
Views Today: 61323

CYDY Stock Quote & Tools

$0.2054 ▲ +0.0054 (+2.69%) As of Oct 15, 3:59 PM EDT
Last0.2054
$ Chg0.0054
Open0.2000
High0.2090
Beta1.4964
Year High0.397
Market Cap301.80M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume3.28M
% Chg+2.69%
Prev Close0.2000
Low0.1971
VWAP0.20198
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. MD VIROLOGIST

    Remember after the press hype about the two most recent vaccines it took the FDA to authorize

  2. jeff67

    If I were Cytodyn exec management team , once I looked at the mortality, and it turned out to be

    (1)
  3. onestepahead

    They were working as quick as they could for mild to moderate investigational trial? No I beg to

  4. ClosetInvestor

    NuGilead was here posting long before you ever were and NuGilead is not a short, I can guarantee

    (1)
  5. ClosetInvestor

    NuGilead. Thanks for the informative post. Havent seen a post from you in a while. Hope all is

    (1)
  6. CDiddy

    11 more days

  7. cardamine

    Probably not worth speculating on since we'll know very soon, but...I speculate he was in the

  8. mtruong34

    You are setting unrealistic expectations if you think we can get any result 2 days after 28-day

    (2)
  9. MD VIROLOGIST

    You are spot on especially # 4. Part of the certification process will be if ALL unblinded

    (1)
  10. Riztheinvestor

    Agree the real heros of the story are the ones taking the chance.

    (2)
  11. 123kidc

    M.F. being a hero, Ll didn't show any SAEs in years. It's a perversion from A -

  12. MarcS

    There was no 75% interim analysis. Because of the pace of enrollment, they forewent (yes, it's a

  13. CDiddy

    I'm guessing he was in the placebo group.

  14. mtruong34

    Excellent work NuGilead on the timelines! Also keep in mind there are over 4x the number of

    (3)
  15. PennySlayer

    Bravo! Those sentiments have been rattling around in my brain for a long time. I could not have

    (3)
  16. MarcS

    It would seem to be at least more than a day, but my impression reading the article, it seems

  17. NuGilead

    It was a long process (but not abmormal), not the 1-2 days people keep posting about on here.

    (21)
  18. nmbr1stckpckr

    A clue would be if he died before or after 3 days. I believe 3 days +/-hours was the number of

    (1)
  19. cardamine

    I hope when this all shakes out, that the families of those who received placebo or SOC are made

    (4)
  20. MD VIROLOGIST

    There has to be initial analytics applied after study completion before unblinding which will take

    (1)
  21. Longestyard

    Did anyone pay close attention to the mm unblinding? Can anyone name and number the steps to the

  22. Boatbuilder

    Barbaric practice. And I certainly hope that IMMEDIATELY after unblinding, should LL be found

    (7)
  23. CDiddy

    It's heartbreaking that we have to prove the efficacy of drugs in this manner.

    (10)
  24. MarcS

    The heroes are the ones who took part in the leronlimab clinical trial, received the placebo and

    (28)
  25. WUM

    Calstang, was intended on my part as a reaction to a previous post in which the graphic without

    (2)
  26. CTMedic

    Calstang, The WaPost article is a repetition of the news out of the UK that tocilizumab and

    (1)
  27. CDiddy

    The drugs won't perform worse, but that ability of our healthcare system to treat patients will

    (2)
  28. calstang

    WUM: What does that Washington Post article say? Many of us are not paying subscribers to the

  29. calstang

    1) the number of covid-19 cases that advance from m/m to s/c is decreasing. But the number of

    (3)
  30. sean007

    Skeuomorph....is an interesting word that germinates from the 19th century...it may cover the

  31. sean007

    "As cases continue to rise the quality of treatment will deteriorate"....NOT so,....if you have an

    (1)
  32. reallypeople?

    From article The data published Thursday showed that patients were given tocilizumab, sarilumab

    (3)
  33. WUM

    interesting numbers for mortality:

  34. onestepahead

    There is drugs and better care for mild moderate still 400,000 people in America alone fall into

    (8)
  35. WUM

    from today's FAZ: "This is compared to a published total mortality rate in German hospitals,

    (4)
  36. CDiddy

    The mortality rate in severe critical isn't dropping.. the progression of patients to severe

    (3)
  37. Rubraquercus

    new drugs, better SOC, and lower mortality

    (1)
  38. TechGuru

    Havasu, Correct, should had specified it better. 47 meant VX deaths (40 SOC). And yes, that

    (6)
  39. ohm20

    For Dr. Patterson, yes. For Cytodyn limiting the patent to leronlimab no problem with getting a

    (1)
  40. ohm20

    I was joking and no don't intentionally get COVID. You never know when things may go sideways. When

    (1)
  41. sean007

    I have dealt with the USPTO.on several occasions.....prior art indicates the scant chance of

  42. sean007

    For Landstreet to characterize both Moderna and Cytodyn in that manner does not provide gravitas to

  43. Eyedr

    Maybe it's actually a good thing we didn't get eua for mild to moderate. The drugs that were aren't

    (2)
  44. MD VIROLOGIST

    The latest on brain involvement:

    (2)
  45. calstang

    Is the conclusion that Cytodyn can meet all the criteria to uplist to NASDAQ since our share price

    (4)
  46. calstang

    Regarding all the talk of p values and death reduction rates, Share holder equity, uplisting

  47. calstang

    Good idea ohm20. Though you may be joking, when leronlimab is available for mild/moderate covid-19,

    (3)
  48. JLang

    Even easier, test enough times and wait for a false positive...

  49. sjacobs26

    I keep an eye on the bi-monthly short numbers and check iborrowdesk periodically too. Simply based

    (4)
  50. Bw

    Ya I watched it happen ... Ppl or someone was covering .... Lots of shares being bought on the tape

    (1)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Adoption of AI and Cloud Technologies Transforming ADM Services

Updated Category News Views 264

The Impact of AI and Cloud on Application Development In recent times, the landscape of application development management (ADM) has seen a remarkable transformation driven by advancements in artificial intelligence (AI) and cloud technologies. U.S. enterprises have increasingly adopted these innovations, leading to significant improvements in their operation efficiency...

Continue Reading
Inspire Medical Systems Faces Lawsuit Over Stock Price Collapse

Updated Category News Views 75

Inspire Medical Systems Faces Legal Challenges Amid Stock Decline Investors in Inspire Medical Systems, Inc. (NYSE: INSP) are encouraged to connect with legal representatives regarding a significant securities class action lawsuit. This movement arises as Inspire's stock takes a substantial downturn, shedding $42.04 per share amidst serious allegations concerning fraud...

Continue Reading
Thanksgiving Special: Celebrating Farming and Sustainability

Updated Category News Views 133

Thanksgiving Special Presentation of The Bullish Farmer The popular show Documentary Showcase will feature a special Thanksgiving Day presentation of the critically acclaimed film The Bullish Farmer. This event will highlight the journey of John "John Boy" Ubaldo, who transitioned from the fast-paced life of Wall Street to embrace the fulfilling role of a family farmer....

Continue Reading
YPF Sociedad Anónima Reveals Results of Its Exchange Offer

Updated Category News Views 96

YPF Sociedad Anónima Shares Details on Exchange Offer YPF S.A. (NYSE: YPF), a notable player in the oil and gas sector, has recently attracted attention by revealing significant outcomes from its exchange offer. The company intends to exchange up to $500,000,000 in principal of its 8.500% Senior Notes set to mature in July 2025 for new 8.750% Senior Notes maturing in...

Continue Reading
Market Recovery Insights: How History Anticipates Gains

Updated Category News Views 175

Market Dynamics Shift as Investors Seize Opportunities In a surprising turn of events, the market breadth has shown signs of recovery, with the number of advancing stocks surpassing those that are declining. This shift comes after a significant streak of 14 sessions during which the S&P 500 index faced negative market breadth, showcasing a challenging climate for...

Continue Reading